At Denovo, we ventured beyond conventional boundaries to augment COVID-19 screening capabilities from a safe distance. Aiming to transcend the limitations of infrared temperature scans, our quest led us to the innovative domain of acquiring oxygen saturation, heart rate, and respiratory rate remotely. Our collaborative endeavors with a prestigious university catalyzed the commercialization of a promising technology with significant implications in combat search and rescue operations, along with remote patient monitoring in hospitals. This trailblazing technology, known as Reflective Photoplethysmography (rPPG), demonstrated versatile operability across diverse platforms like UAVs, mobile phones, and computers.

     From conceptual sketches to tangible prototypes and commercial products, Denovo's journey epitomizes meticulous craftsmanship and forward-thinking. Our proactive approach facilitated smooth software integration across a multitude of platforms, besides establishing robust supply chains and refining delivery optimization protocols. This venture not only contributed to Gennaro's recognition as a Top 100 Innovator in Healthcare but also underscored our commitment to redefining the MedTech landscape through the commercialization of this groundbreaking platform